Clinical Trial Update: Real Life Assessment of Abilify Maintena

View source ↗

Summary

A real-life assessment trial of Abilify Maintena (aripiprazole long-acting injectable) for schizophrenia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ABILIFY MAINTENA (ARIPIPRAZOLE)

Snippet

Sponsor: Lundbeck Canada Inc. | Conditions: Schizophrenia | Status: TERMINATED